Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript
Geron Corporation beats earnings expectations. Reported EPS is $-0.09178, expectations were $-0.1.
Geron Corp (GERN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 46,202,425 | $152,468,003 | 1.93% | |
| 2. | Deep Track Capital David Kroin | 30,505,929 | $100,669,566 | +4% | 2.88% |
| 3. | Vivo Capital Albert Cha And Frank Kung | 27,225,292 | $89,843,464 | +13% | 7.05% |
| 4. | OrbiMed Advisors Samuel Isaly | 12,893,611 | $42,548,916 | +2559% | 0.77% |
| 5. | BioImpact Capital Mpm Capital | 10,475,675 | $34,569,728 | -3% | 5.55% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.28 | 6,579 | Director | 26,220 | 2023-08-24 | Filing | |
| $2.28 | 6,607 | Director | 7,407 | 2023-08-24 | Filing | |
| $1.73 | 17,441 | Director | 19,641 | 2020-08-21 | Filing | |
| $1.34 | 2,200 | Director | 2,200 | 2020-01-10 | Filing | |
| $1.35 | 800 | Director | 800 | 2020-01-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.75 | 35,000 | 0 | 2024-05-15 | Filing | ||
| $3.00 | 35,000 | Director | 0 | 2023-05-11 | Filing | |
| $2.48 | 35,000 | Director | 0 | 2023-05-01 | Filing | |
| $3.03 | 234,719 | Officer | 0 | 2023-02-09 | Filing | |
| $3.03 | 150,000 | Officer | 234,719 | 2023-02-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 42,172,679 | $88,984,353 | 0% | |
| 2. | 28,564,574 | $60,271,251 | 0% | |
| 3. | 25,625,606 | $54,070,029 | 0% | |
| 4. | 23,375,839 | $49,323,020 | 5.46% | |
| 5. | 22,776,409 | $48,058,223 | 3.2% |
News See All
Geron Corporation (NASDAQ:GERN) Q4 2023 Earnings Call Transcript
Geron Corporation beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1.
Geron Corporation (NASDAQ:GERN) Q3 2023 Earnings Call Transcript
Operator: Good morning. My name is Audrey, and I will be your conference operator today.
12 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the 12 best high risk high reward stocks to buy now.
Geron Corporation (NASDAQ:GERN) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, everyone. Welcome to the Geron Corporation Second Quarter 2023 Earnings Conference Call.
Geron Corporation (NASDAQ:GERN) Q1 2023 Earnings Call Transcript
Operator: Good morning. My name is Rob, and I will be your conference operator today.
5 Best Stocks To Buy For A Stock Market Game
In this article, we will be taking a look at the 5 best stocks to buy for a stock market game.
Geron Corporation (NASDAQ:GERN) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. My name is Emma and I will be your conference operator today.
10 Hot Healthcare Stocks To Buy Now
The rise of consumer prices has often lagged behind healthcare inflation, which includes costs for doctor visits, surgeries, and prescription drugs.
5 Best Penny Stocks to Buy Now
Geron Corporation (NASDAQ:GERN), located in Foster City, California, is a biotechnology company. The company makes cancer-treating drugs that block telomeras.
Billionaire Hedge Funds
